Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTABLET, EXTENDED RELEASEGeneric

AMPHETAMINE

AMPHETAMINE

Standard Dose
10MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary

Approval overview AMPHETAMINE is listed in Drugs@FDA under application 220284 (ANDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient AMPHETAMINE Form and strength TABLET, EXTENDED RELEASE - 10MG Sponsor GRANULES PHARMACEUTICALS INC Submission history Latest submission status date: 2026-01-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMPHETAMINE is listed in Drugs@FDA under application 220284 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient AMPHETAMINE Form and strength TABLET, EXTENDED RELEASE - 10MG Sponsor GRANULES PHARMACEUTICALS INC Submission history Latest submission status date: 2026-01-07 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.